Anupam Rasayan Commercializes ETFA Production Using Continuous Flow Chemistry Technology
Anupam Rasayan India Ltd has become the first company globally to commercialize Ethyl trifluoroacetate (ETFA) production using its proprietary continuous flow chemistry technology. This method offers advantages over traditional batch processes, including enhanced safety, scalability, efficiency, and a lower environmental impact. ETFA is a key fluorinated building block used in pharmaceuticals, life sciences, and performance materials, with a global market estimated at USD 500-600 million. The company emphasizes ongoing investment in innovation and sustainable manufacturing.
First-hand measurement across 3 sources
We measured how 3 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 100%, Right 0%). Overall sentiment is positive (75/100). Lens Score 29/100 — low public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- economictimes— balanced framing, positive sentiment
- news18— balanced framing, positive sentiment
- mint— balanced framing, positive sentiment
AI Analysis
The articles primarily present a corporate and technological perspective without political framing. Coverage focuses on Anupam Rasayan's innovation and market impact, reflecting business and industry viewpoints. There is no evident political bias, as the sources emphasize technological advancement and commercial milestones rather than political or ideological interpretations.
The overall tone across the articles is positive, highlighting the company's pioneering achievement and technological innovation. The language underscores benefits such as safety, efficiency, and environmental advantages, portraying the development as a significant milestone. There is no critical or negative sentiment present, reflecting an optimistic outlook on the company's progress.
How 3 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.